| Investor Type | Firm |
| Investing | Israel |
| Investment Range | $3,000,000 - $9,000,000 |
Yissum Research Development Company is the technology transfer arm of the Hebrew University of Jerusalem, dedicated to translating pioneering academic research into commercial opportunities. With its roots deeply entrenched in the rich scientific heritage of the Hebrew University, Yissum is entrusted with marketing the inventions and intellectual property developed by its world-class researchers and students.
The company operates across varied sectors, showcasing a wide spectrum of available technologies in fields such as Agriculture Technology (AgTech), Chemistry and Nanotechnology, Computer Science and Engineering, Diagnostics, Food Technology and Nutrition, Medical Devices and Digital Health, Micro and Optoelectronics, Pharmaceuticals, Quantum Science, Social Sciences, Sustainability and Environment, and Veterinary Technology (VetTech).
Yissum's efforts are exemplified in its diverse portfolio, which boasts significant advancements in these areas.
For instance, recent highlights include breakthroughs in cancer research and the unveiling of Israel's first 20-qubit quantum computer. Yissum seeks to foster industry and investor partnerships through various models, including venture funds and educational workshops.
The company has a stated investment range, with a minimum investment of 3 million and a maximum of 9 million. Their commitment to innovation is also reflected in their support of faculty and researchers, as well as in their active participation in global conversations about technology transfer.
Yissum's goal is not just to advance academic research but to mold it into real-world applications that can meet society's evolving challenges, thereby generating lasting impact. Their comprehensive website offers detailed insights into their areas of expertise, partnership models, success stories, and news about the latest research and development from the Hebrew University.

